Barings’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-64,400
| Closed | -$189K | – | 982 |
|
|
2018
Q1 | $189K | Hold |
64,400
| – | – | ﹤0.01% | 887 |
|
|
2017
Q4 | $176K | Hold |
64,400
| – | – | ﹤0.01% | 925 |
|
|
2017
Q3 | $218K | Hold |
64,400
| – | – | ﹤0.01% | 819 |
|
|
2017
Q2 | $159K | Sell |
64,400
-64,400
| -50% | -$159K | ﹤0.01% | 827 |
|
|
2017
Q1 | $292K | Buy |
128,800
+64,400
| +100% | +$146K | ﹤0.01% | 980 |
|
|
2016
Q4 | $137K | Hold |
64,400
| – | – | ﹤0.01% | 855 |
|
|
2016
Q3 | $216K | Hold |
64,400
| – | – | 0.01% | 743 |
|
|
2016
Q2 | $202K | Sell |
64,400
-25,400
| -28% | -$79.7K | 0.01% | 858 |
|
|
2016
Q1 | $299K | Buy |
89,800
+26,700
| +42% | +$88.9K | 0.01% | 804 |
|
|
2015
Q4 | $223K | Hold |
63,100
| – | – | 0.01% | 846 |
|
|
2015
Q3 | $317K | Buy |
63,100
+52,400
| +490% | +$263K | 0.01% | 740 |
|
|
2015
Q2 | $69K | Hold |
10,700
| – | – | ﹤0.01% | 957 |
|
|
2015
Q1 | $75K | Sell |
10,700
-1,500
| -12% | -$10.5K | ﹤0.01% | 946 |
|
|
2014
Q4 | $94K | Hold |
12,200
| – | – | ﹤0.01% | 917 |
|
|
2014
Q3 | $91K | Sell |
12,200
-4,200
| -26% | -$31.3K | ﹤0.01% | 933 |
|
|
2014
Q2 | $159K | Sell |
16,400
-2,200
| -12% | -$21.3K | ﹤0.01% | 939 |
|
|
2014
Q1 | $155K | Hold |
18,600
| – | – | ﹤0.01% | 890 |
|
|
2013
Q4 | $157K | Sell |
18,600
-3,100
| -14% | -$26.2K | 0.01% | 888 |
|
|
2013
Q3 | $173K | Buy |
+21,700
| New | +$173K | 0.01% | 895 |
|